August 19, 2025, London, United Kingdom: iPMI Global, the leading strategic media consultancy and business intelligence provider for the International Private Medical Insurance (IPMI) market, proudly celebrates its 14th anniversary August 2025. Since its inception in 2011, the business has played a pivotal role in shaping the global health insurance landscape through data-driven insights, specialist advisory services, and deep market expertise.

In this iPMI Global insights article we explore NHS England's approach to pandemic preparedness and detail Exercise Pegasus, a significant cross-government simulation scheduled for autumn 2025. This exercise, the first of its kind in almost a decade, aims to evaluate the UK's pandemic response capabilities across various government departments and devolved nations, with NHS England as a key participant.

In this iPMI Global insights article, we look at Lloyd's strategic expansion of its multinational insurance capabilities through a new partnership with Grupo Mexicano de Seguros (GMX) in Mexico. This collaboration allows Lloyd's to offer compliant and consistent insurance coverage across various territories, bypassing the need for separate local policy arrangements in many cases. GMX will issue local policies for specific lines of business, streamlining the process for managing agents. This initiative builds on previous successful partnerships, aiming to enhance Lloyd's global network and provide market participants with improved access to key markets and a broader range of insurance solutions.

In this iPMI Global Insights article, we take a look at the disadvantages of applying VAT to Private Healthcare in the UK. We examine the potential negative consequences of introducing Value Added Tax on private healthcare services. iPMI Global argues that such a policy shift, which would apply the standard 20% VAT rate to currently exempt services, could increase pressure on the National Health Service (NHS) by driving patients back to the public system.

The Capgemini Research Institute’s World Wealth Report 2025 reveals the global high-net-worth individuals^[1] (HNWIs)population rose by 2.6% in 2024. Now in its 29^th edition, the report finds this increase was driven by the growth in the population of ultra-high-net-worth individuals (UHNWIs), which grew by 6.2%, as strong stock markets and AI optimism boosted portfolio returns. The data indicates that alternative investments^[2], such as private equity and cryptocurrencies, are now an established presence in HNWI holdings, representing 15% of their portfolios.

In this iPMI Global Insights article, we help you learn all about international private medical insurance (iPMI) for High Net Worth Individuals. We read expert opinions from various leaders in the international private medical insurance (IPMI) sector regarding High-Net-Worth Individuals (HNWIs). The discussions focus on defining HNWIs within IPMI, examining the market's significant growth potential, and exploring why HNWIs opt for IPMI despite their financial capacity to self-fund.

In this iPMI Global Insights article, we read the recent iPMI Global LATAM iPMI Strategies Round Table, and ask, how important is the selection and subsequent vetting of network partners? Is Due diligence important?

Firstly, vetting ensures access to a network of quality healthcare providers, hospitals, and clinics. AP Companies highlights the importance of their "extensive global medical network, featuring top-tier healthcare providers, hospitals, and clinics across LATAM". This suggests that a process of vetting is necessary to guarantee that the network consists of reliable and high-standard medical facilities and professionals.

In this iPMI Global Insights Article we explore all the latest news from iPMI Global. 

iPMI Global is the leading business intelligence provider for international private medical, health, travel and expatriate insurance markets worldwide. Due to the nomadic nature of the international private medical insurance (IPMI) market, iPMI Global is an internet based news service for worldwide insurance and medical assistance professionals who need to understand the impacts of insurance and healthcare policy, regulatory, and legislative developments.

Senior level business executives, in over 120 countries, rely on iPMI Global to stay 1 step ahead of the risk and on the inside track of international PMI.

Covering business travellers, high net worth individuals, expatriate and leisure travel markets, iPMI Global is the only international news source covering the most exciting sector of international health insurance: international private medical insurance.

Bupa's full-year statement for 2024 reveals significant growth in customers and revenue, alongside a substantial increase in underlying and statutory profit before taxation. This positive financial performance was supported by strong growth across various market units, including Asia Pacific and Europe & Latin America, and higher investment returns. A key development was the increase in Bupa's stake in Niva Bupa, an Indian health insurance company, which was subsequently listed on the stock exchange. 

The iPMI Global Provider Network offers an online provider network directory intended as a buyer's guide for industry payers and providers. It contains pertinent company information to assist buyers in connecting with relevant global payers and providers.